Johnson & Johnson (NYSE:JNJ) reported quarterly earnings results on January 21, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $2.46, missing the consensus estimate of $2.46 by $0.00 per share. Revenue came in at , missing the estimate of $24.4B.
Johnson & Johnson's stock moved following the earnings release. The stock currently trades at $220.03 with a market capitalization of $505.8B.
